Stock 2802 AJINOMOTO CO., INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Ajinomoto Co., Inc.

Equities

2802

JP3119600009

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-04-18 am EDT 		5-day change 1st Jan Change
5,514 JPY +0.02% Intraday chart for Ajinomoto Co., Inc. -1.18% +1.36%
Mar. 27 Transcript : Ajinomoto Co., Inc. - Analyst/Investor Day
Mar. 27 TechMagic, Inc. announced that it has received funding from a group of investors CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Final dividend
FA
Transcript : Ajinomoto Co., Inc. - Analyst/Investor Day
Ajinomoto : Enhancing Corporate Value through ASV Management
PU
Ajinomoto : Sustainability Initiatives Aimed at Enhancement of Corporate Value
PU
TechMagic, Inc. announced that it has received funding from a group of investors
CI
Ajinomoto Co., Inc. Enhances StemFit iPS Cell Expansion Medium
CI
Ajinomoto (Malaysia) Closes MYR408 Million Sale of Six Kuala Lumpur Land Plots
MT
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.
CI
Ajinomoto Co., Inc.'s Equity Buyback announced on November 13, 2023, has closed with 7,003,300 shares, representing 1.35% for ¥39,999.85 million.
CI
Tsubame BHB Co., Ltd. announced that it has received ¥5.3 billion in funding from a group of investors
CI
Ajinomoto Foods Restates Commitment to Quality Products
AQ
Transcript : Ajinomoto Co., Inc., Q3 2024 Earnings Call, Feb 06, 2024
Inglewood Co., Ltd. announced that it has received funding from Ajinomoto Co., Inc.
CI
Ribomic and Ajinomoto Co. Partner for Nucleic Acid Aptamer Research
MT
Ribomic Enters Into Drug Research Collaboration with Ajinomoto
MT
RIBOMIC Inc. and Ajinomoto Co., Inc. Announce Joint Research Agreement
CI
Tranche Update on Ajinomoto Co., Inc.'s Equity Buyback Plan announced on November 13, 2023.
CI
Transcript : Ajinomoto Co., Inc. - Special Call
New acquisition to support global gene therapy manufacturing
AQ
Forge Biologics - Ajinomoto Co., Inc. to Acquire Forge Biologics for $620 Million1
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2802 Stock
  4. News Ajinomoto Co., Inc.